THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE
Ulcerative colitis (UC) is a chronic disease characterized by immune diffuse inflammation of the mucosa of the colon with mandatory involvement in the inflammatory process of the rectum. The choice of conservative or surgical treatment depends upon the severity of the attack, extent of lesions of th...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2018-01-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2239 |
| _version_ | 1797842146973188096 |
|---|---|
| author | O. V. Knyazev A. V. Kagramanova |
| author_facet | O. V. Knyazev A. V. Kagramanova |
| author_sort | O. V. Knyazev |
| collection | DOAJ |
| description | Ulcerative colitis (UC) is a chronic disease characterized by immune diffuse inflammation of the mucosa of the colon with mandatory involvement in the inflammatory process of the rectum. The choice of conservative or surgical treatment depends upon the severity of the attack, extent of lesions of the colon, presence of extraintestinal manifestations, duration of disease, efficacy and safety of past therapy and the risk of complications UC. In Russia and abroad for the treatment and prevention of relapses of UC are widely used mesalazine having minimum side effects. Our study shows high adherence of patients to receive drugs 5-ASA and the positive impact of the use of oral medications 5-ASA Salofalk and Asacol for the maintenance of remission in patients UC moderate severity in clinical practice. This study also showed the importance of long-term use (at least 12 months) drugs 5-ASA to maintain remission and reduce the risk of disease recurrence. |
| first_indexed | 2024-04-09T16:43:05Z |
| format | Article |
| id | doaj.art-0c179aee105c4feeabb2d43605870361 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:43:05Z |
| publishDate | 2018-01-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-0c179aee105c4feeabb2d436058703612023-04-23T06:56:35ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-01-0102010811710.21518/2079-701X-2017-20-108-1172216THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICEO. V. Knyazev0A. V. Kagramanova1Loginov Moscow Clinical Scientific Center of the Moscow Department of Healthcare.Loginov Moscow Clinical Scientific Center of the Moscow Department of Healthcare.Ulcerative colitis (UC) is a chronic disease characterized by immune diffuse inflammation of the mucosa of the colon with mandatory involvement in the inflammatory process of the rectum. The choice of conservative or surgical treatment depends upon the severity of the attack, extent of lesions of the colon, presence of extraintestinal manifestations, duration of disease, efficacy and safety of past therapy and the risk of complications UC. In Russia and abroad for the treatment and prevention of relapses of UC are widely used mesalazine having minimum side effects. Our study shows high adherence of patients to receive drugs 5-ASA and the positive impact of the use of oral medications 5-ASA Salofalk and Asacol for the maintenance of remission in patients UC moderate severity in clinical practice. This study also showed the importance of long-term use (at least 12 months) drugs 5-ASA to maintain remission and reduce the risk of disease recurrence.https://www.med-sovet.pro/jour/article/view/2239asacolulcerative colitismesalazinesalofalc |
| spellingShingle | O. V. Knyazev A. V. Kagramanova THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE Медицинский совет asacol ulcerative colitis mesalazine salofalc |
| title | THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE |
| title_full | THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE |
| title_fullStr | THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE |
| title_full_unstemmed | THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE |
| title_short | THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE |
| title_sort | results of the use of 5 aminosalicylic acid as an anti relapse and maintenance therapy ulcerative colitis moderate severity in clinical practice |
| topic | asacol ulcerative colitis mesalazine salofalc |
| url | https://www.med-sovet.pro/jour/article/view/2239 |
| work_keys_str_mv | AT ovknyazev theresultsoftheuseof5aminosalicylicacidasanantirelapseandmaintenancetherapyulcerativecolitismoderateseverityinclinicalpractice AT avkagramanova theresultsoftheuseof5aminosalicylicacidasanantirelapseandmaintenancetherapyulcerativecolitismoderateseverityinclinicalpractice AT ovknyazev resultsoftheuseof5aminosalicylicacidasanantirelapseandmaintenancetherapyulcerativecolitismoderateseverityinclinicalpractice AT avkagramanova resultsoftheuseof5aminosalicylicacidasanantirelapseandmaintenancetherapyulcerativecolitismoderateseverityinclinicalpractice |